Search Results - "Konda, Prathyusha"

Refine Results
  1. 1

    Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433 by Monro, Susan, Colón, Katsuya L, Yin, Huimin, Roque, John, Konda, Prathyusha, Gujar, Shashi, Thummel, Randolph P, Lilge, Lothar, Cameron, Colin G, McFarland, Sherri A

    Published in Chemical reviews (23-01-2019)
    “…Transition metal complexes are of increasing interest as photosensitizers in photodynamic therapy (PDT) and, more recently, for photochemotherapy (PCT). In…”
    Get full text
    Journal Article
  2. 2

    How splicing confers treatment resistance in prostate cancer by Konda, Prathyusha, Viswanathan, Srinivas R

    Published in eLife (23-08-2022)
    “…A splice variant of the androgen receptor that drives prostate cancer resistance translocates into the nucleus using a different mechanism from the full-length…”
    Get full text
    Journal Article
  3. 3

    Genome-guided discovery of cancer therapeutic targets by Konda, Prathyusha, Garinet, Simon, Van Allen, Eliezer M., Viswanathan, Srinivas R.

    Published in Cell reports (Cambridge) (29-08-2023)
    “…The success of precision oncology—which aims to match the right therapies to the right patients based on molecular status—is predicated on a robust pipeline of…”
    Get full text
    Journal Article
  4. 4

    Closely related reovirus lab strains induce opposite expression of RIG-I/IFN-dependent versus -independent host genes, via mechanisms of slow replication versus polymorphisms in dsRNA binding σ3 respectively by Mohamed, Adil, Konda, Prathyusha, Eaton, Heather E., Gujar, Shashi, Smiley, James R., Shmulevitz, Maya

    Published in PLoS pathogens (01-09-2020)
    “…The Dearing isolate of Mammalian orthoreovirus (T3D) is a prominent model of virus-host relationships and a candidate oncolytic virotherapy. Closely related…”
    Get full text
    Journal Article
  5. 5

    Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy by Konda, Prathyusha, Lifshits, Liubov M., Roque, John A., Cole, Houston D., Cameron, Colin G., McFarland, Sherri A., Gujar, Shashi

    Published in Oncoimmunology (01-01-2021)
    “…We report a new class of ruthenium (Ru)-based photosensitizers that induce potent cytotoxicity in melanoma cells following activation with NIR light. In…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells by Vidovic, Dejan, Huynh, Thomas T., Konda, Prathyusha, Dean, Cheryl, Cruickshank, Brianne M., Sultan, Mohammad, Coyle, Krysta M., Gujar, Shashi, Marcato, Paola

    Published in Cell death and differentiation (01-01-2020)
    “…To discover novel therapeutic targets for triple-negative breast cancer (TNBC) and cancer stem cells (CSCs), we screened long non-coding RNAs (lncRNAs) most…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy by Gujar, Shashi, Pol, Jonathan G., Kumar, Vishnupriyan, Lizarralde-Guerrero, Manuela, Konda, Prathyusha, Kroemer, Guido, Bell, John C.

    Published in Nature protocols (01-09-2024)
    “…Oncolytic viruses (OVs) represent a novel class of cancer immunotherapy agents that preferentially infect and kill cancer cells and promote protective…”
    Get full text
    Journal Article
  11. 11

    Improving MHC‐I Ligand Identifications from LC‐MS/MS Data by Incorporating Allelic Peptide Motifs by Konda, Prathyusha, Murphy, J. Patrick, Gujar, Shashi

    Published in Proteomics (Weinheim) (01-03-2019)
    “…MHC class I (MHC‐I)‐bound ligands play a pivotal role in CD8 T cell immunity and are hence of major interest in understanding and designing immunotherapies…”
    Get full text
    Journal Article
  12. 12

    Cytokines in oncolytic virotherapy by Pol, Jonathan G., Workenhe, Samuel T., Konda, Prathyusha, Gujar, Shashi, Kroemer, Guido

    Published in Cytokine & growth factor reviews (01-12-2020)
    “…Tumors represent a hostile environment for the effector cells of cancer immunosurveillance. Immunosuppressive receptors and soluble or membrane-bound ligands…”
    Get full text
    Journal Article
  13. 13

    Improving MHC-I Ligand Identification by Incorporating Targeted Searches of Mass Spectrometry Data by Konda, Prathyusha, Murphy, J Patrick, Gujar, Shashi

    “…Effective immunotherapies rely on specific activation of immune cells. Class I major histocompatibility complex (MHC-I) bound peptide ligands play a major role…”
    Get more information
    Journal Article
  14. 14

    Near-infrared absorbing Ru() complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanoma by Lifshits, Liubov M, Roque III, John A, Konda, Prathyusha, Monro, Susan, Cole, Houston D, von Dohlen, David, Kim, Susy, Deep, Gagan, Thummel, Randolph P, Cameron, Colin G, Gujar, Shashi, McFarland, Sherri A

    Published in Chemical science (Cambridge) (21-11-2020)
    “…Mounting evidence over the past 20 years suggests that photodynamic therapy (PDT), an anticancer modality known mostly as a local treatment, has the capacity…”
    Get full text
    Journal Article
  15. 15

    Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities by Kim, Youra, Konda, Prathyusha, Murphy, J. Patrick, Paulo, Joao A., Gygi, Steven P., Gujar, Shashi

    Published in Molecular & cellular proteomics (01-02-2022)
    “…The combination cancer immunotherapies with oncolytic virus (OV) and immune checkpoint blockade (ICB) reinstate otherwise dysfunctional antitumor CD8 T cell…”
    Get full text
    Journal Article
  16. 16
  17. 17

    RTN4 Knockdown Dysregulates the AKT Pathway, Destabilizes the Cytoskeleton, and Enhances Paclitaxel-Induced Cytotoxicity in Cancers by Pathak, Gopal P., Shah, Rashmi, Kennedy, Barry E., Murphy, J. Patrick, Clements, Derek, Konda, Prathyusha, Giacomantonio, Michael, Xu, Zhaolin, Schlaepfer, Isabel R., Gujar, Shashi

    Published in Molecular therapy (01-08-2018)
    “…[Display omitted] Reticulon-4 (RTN4), commonly known as a neurite outgrowth inhibitor (Nogo), is emerging as an important player in human cancers. Clinically,…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Enhancing Mass Spectrometry-Based MHC-I Peptide Identification Through a Targeted Database Search Approach by Konda, Prathyusha, Murphy, J Patrick, Nielsen, Morten, Gujar, Shashi

    “…MHC-bound peptide ligands dictate the activation and specificity of CD8+ T- cells-based and thus are important for devising T-cell immunotherapies. In recent…”
    Get more information
    Journal Article
  20. 20

    Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic Reovirus by Kennedy, Barry E, Murphy, John Patrick, Clements, Derek R, Konda, Prathyusha, Holay, Namit, Kim, Youra, Pathak, Gopal P, Giacomantonio, Michael A, Hiani, Yassine El, Gujar, Shashi

    Published in Cancer research (Chicago, Ill.) (01-08-2019)
    “…Oncolytic viruses (OV) such as reovirus preferentially infect and kill cancer cells. Thus, the mechanisms that dictate the susceptibility of cancer cells to…”
    Get full text
    Journal Article